BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24136223)

  • 1. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
    Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
    Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
    Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
    Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.
    Sapkota GP; Cummings L; Newell FS; Armstrong C; Bain J; Frodin M; Grauert M; Hoffmann M; Schnapp G; Steegmaier M; Cohen P; Alessi DR
    Biochem J; 2007 Jan; 401(1):29-38. PubMed ID: 17040210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.
    Pambid MR; Berns R; Adomat HH; Hu K; Triscott J; Maurer N; Zisman N; Ramaswamy V; Hawkins CE; Taylor MD; Dunham C; Guns E; Dunn SE
    Pediatr Blood Cancer; 2014 Jan; 61(1):107-15. PubMed ID: 23940083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870.
    Edgar AJ; Trost M; Watts C; Zaru R
    Biosci Rep; 2014 Feb; 34(1):. PubMed ID: 27919044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSK Inhibition Induces Apoptosis by Downregulating Protein Synthesis in a Variety of Acute Myeloid Leukemia Cell Lines.
    Katayama K; Nishihata A
    Biol Pharm Bull; 2021 Dec; 44(12):1843-1850. PubMed ID: 34602526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
    Abdulrahman N; Siveen KS; Joseph JM; Osman A; Yalcin HC; Hasan A; Uddin S; Mraiche F
    J Pharm Pharmacol; 2020 Nov; 72(11):1536-1545. PubMed ID: 32667058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma.
    Chiu CF; Bai LY; Kapuriya N; Peng SY; Wu CY; Sargeant AM; Chen MY; Weng JR
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):237-47. PubMed ID: 24241211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.
    Stratford AL; Reipas K; Hu K; Fotovati A; Brough R; Frankum J; Takhar M; Watson P; Ashworth A; Lord CJ; Lasham A; Print CG; Dunn SE
    Stem Cells; 2012 Jul; 30(7):1338-48. PubMed ID: 22674792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DEAD-box RNA helicase DDX41 is a novel repressor of p21
    Peters D; Radine C; Reese A; Budach W; Sohn D; Jänicke RU
    J Biol Chem; 2017 May; 292(20):8331-8341. PubMed ID: 28348086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
    Smith JA; Poteet-Smith CE; Xu Y; Errington TM; Hecht SM; Lannigan DA
    Cancer Res; 2005 Feb; 65(3):1027-34. PubMed ID: 15705904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation.
    Li P; Goto H; Kasahara K; Matsuyama M; Wang Z; Yatabe Y; Kiyono T; Inagaki M
    Mol Biol Cell; 2012 Apr; 23(8):1582-92. PubMed ID: 22357623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractility.
    Artamonov M; Momotani K; Utepbergenov D; Franke A; Khromov A; Derewenda ZS; Somlyo AV
    PLoS One; 2013; 8(3):e58703. PubMed ID: 23516539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
    Astanehe A; Finkbeiner MR; Krzywinski M; Fotovati A; Dhillon J; Berquin IM; Mills GB; Marra MA; Dunn SE
    Oncogene; 2012 Oct; 31(41):4434-46. PubMed ID: 22249268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.
    Abe Y; Yoon SO; Kubota K; Mendoza MC; Gygi SP; Blenis J
    J Biol Chem; 2009 May; 284(22):14939-48. PubMed ID: 19332537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
    Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
    Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90(RSK) in the control of mTORC1 protein signaling by phorbol esters.
    Fonseca BD; Alain T; Finestone LK; Huang BP; Rolfe M; Jiang T; Yao Z; Hernandez G; Bennett CF; Proud CG
    J Biol Chem; 2011 Aug; 286(31):27111-22. PubMed ID: 21659537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.